• Register
  • Login

Iranian Journal of Pharmaceutical Sciences

  • Home
  • Journal Info
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Indexing & Abstracting
    • Privacy Statement
    • Contact us
  • Issues
    • Current
    • Archives
  • New Submissions
  • Author Guidelines
  • Policies & Process
    • Peer Review
    • Publication Ethics
    • Open Access Policy
    • Plagiarism
    • Retraction Policies
    • Archiving
  • Ethical Considration
Advanced Search
  1. Home
  2. Archives
  3. Vol. 14 No. 1 (2018): IJPS_Volume 14_Issue 1 (2018)
  4. Research/Original Articles

Vol. 14 No. 1 (2018)

January 2018

Prioritizing the Factors Affecting the Abuse of Pharmaceutical Opioids by Applying Topsis Factors Affecting the Abuse of Pharmaceutical Opioids

  • Farahnaz Zeinali
  • Mehdi Mohammadzadeh
  • Jamshid Salamzadeh

Iranian Journal of Pharmaceutical Sciences, Vol. 14 No. 1 (2018), 15 January 2018 , Page 67-74
https://doi.org/10.22037/ijps.v14.40673

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Human societies have witnessed the phenomenon of ever-increasing use of pharmaceutical opioids for a long time. Moreover, cultural, social, and economic aspects in any community have undergone the negative effects of the growing tendency toward opioids addiction. Since abusing pharmaceutical opioids is a serious problem, it is important to recognize and prioritize the factors influencing this abuse. This paper concentrates on assessing the priorities of variables which have effects on the abuse of pharmaceutical opioids in order to help the policy makers to make correct decisions to reduce the abuse of opioids.Topsis is applied as a method for Multi-Attribute decision making, which prioritizes alternatives in a simple but efficient way. Topsis method identifies the closeness of each alternative to the ideal solution. In this method, each alternative should have the shortest distance from the best solution and the farthest distance from the worst solution. According to the findings, ―family role‖ and ―extra prescription‖ are the most important factors in variables.

Keywords:
  • Pharmaceutical opioids
  • Abuse
  • Topsis
  • Prioritization
  • Affecting Factors
  • Iran
  • IJPS_Volume 14_Issue 1_Pages 67-74

How to Cite

Farahnaz Zeinali, Mehdi Mohammadzadeh, & Jamshid Salamzadeh. (2018). Prioritizing the Factors Affecting the Abuse of Pharmaceutical Opioids by Applying Topsis: Factors Affecting the Abuse of Pharmaceutical Opioids. Iranian Journal of Pharmaceutical Sciences, 14(1), 67–74. https://doi.org/10.22037/ijps.v14.40673
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

[1] Fartookzadeh, H., H. Moazzez, and M. RajabiNohouji, Strategies and Policies of Drug Abuse Control in Iran. Social Welfare Quarterly, 2013. 13(48): p. 171-199.
[2] LaxmaiahManchikanti, M., M. SairamAtluri, and M. Hans Hansen, Opioids in chronic noncancer pain: have we reached a boiling point yet? Pain Physician, 2014. 17: p. E1-E10.
[3] Davis, W.R. and B.D. Johnson, Prescription opioid use, misuse, and diversion among street drug users in
[4] Compton, W.M. and N.D. Volkow, Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug and alcohol dependence, 2006. 81(2): p. 103-107.
[5] Højsted, J. and P. Sjøgren, Addiction to opioids in chronic pain patients: a literature review. European Journal of Pain, 2007. 11(5): p. 490-518.
[6] Eriksen, J., et al., Epidemiology of chronic non-malignant pain in Denmark. Pain, 2003. 106(3): p.
[7] Warner, M., L.H. Chen, and D.M. Makuc, Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS data brief, 2009(22): p. 1-8.
[8] Morden, N.E., et al., Prescription Opioid Use among Disabled Medicare Beneficiaries: Intensity, Trends and Regional Variation. Medical care, 2014. 52(9): p. 852.
[9] Nelson, L.S. and J. Perrone, Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS). Jama, 2012. 308(5): p. 457-458.
[10] Chou, R., et al., Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. The Journal of Pain, 2009. 10(2): p. 147-159. e15.
[11] Lai, Y.-J., T.-Y. Liu, and C.-L. Hwang, Topsis for MODM. European Journal of Operational Research, 1994. 76(3): p. 486-500.
[12] Hwang, C.-L. and K. Yoon, Multiple attribute decision making: methods and applications a state-of-the-art survey. Vol. 186. 2012: Springer Science & Business Media.
[13] Olson, D.L., Comparison of weights in TOPSIS models. Mathematical and Computer Modelling, 2004. 40(7-8): p. 721-727.
[14] Opricovic, S. and G.-H. Tzeng, Compromise solution by MCDM methods: A comparative analysis of VIKOR and TOPSIS. European journal of operational research, 2004. 156(2): p. 445-455.
[15] Doyle, J.K. and D.N. Ford, Mental models concepts for system dynamics research. System dynamics review, 1998. 14(1): p. 3-29.
[16] Pradel, V., et al., Impact of a prescription monitoring program on doctor‐shopping for high
[17] Gilson, A.M., et al., A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. Journal of pain and symptom management, 2004. 28(2): p. 176-188.
[18] Wakeland, W., et al., Modeling the Impact of Simulated Educational Interventions on the Use and Abuse of Pharmaceutical Opioids in the United States A Report on Initial Efforts. Health Education & Behavior, 2013. 40(1 suppl): p. 74S-86S.
[19] Hall, A.J., et al., Patterns of abuse among unintentional pharmaceutical overdose fatalities. Jama, 2008. 300(22): p. 2613-2620.
[20] Wakeland, W., A. Nielsen, and T.D. Schmidt, System Dynamics Modeling of Medical Use, Nonmedical Use and Diversion of Prescription Opioid Analgesics. 2012.
  • Abstract Viewed: 397 times
  • IJPS_Volume 14_Issue 1_Pages 67-74 Downloaded: 200 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Print ISSN: 1735-2444

Online ISSN: 2252-0457

Powered by OJSPlus